FindTrial
Sign In

Betablocker

DRUG2 trials

Sponsors

Oslo University Hospital, Post Graduate Institute of Medical Education and Research, Chandigarh

Conditions

Acute Myocardial InfarctionCirrhosis, LiverCirrhotic CardiomyopathyLeft Ventricular DysfunctionNon-ST Elevation Myocardial InfarctionPortal HypertensionST Elevation Myocardial Infarction

Phase 4

BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
Active, not recruitingNCT03646357
Oslo University HospitalAcute Myocardial Infarction, Non-ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction
Start: 2018-10-01End: 2035-12-10Updated: 2025-06-08

Unknown Phase

Ivabradine in Cirrhotic Cardiomyopathy
RecruitingNCT04111133
Post Graduate Institute of Medical Education and Research, ChandigarhCirrhosis, Liver, Cirrhotic Cardiomyopathy, Left Ventricular Dysfunction +1
Start: 2020-01-01End: 2024-12-31Target: 130Updated: 2024-02-13

Related Papers

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure
New England Journal of Medicine2025-08-3027 citations
Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial
BMJ Open2024-08-018 citations
Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
BMC Cardiovascular Disorders2022-04-2614 citations
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
2020-05-2338 citations